1. Home
  2. Clinical Topics
  3. New FDA regulation for improving safety reporting in clinical trials discussed in The New England Journal of Medicine.
Clinical TopicsDrugs and DevicesNewsPatient SafetyWeb ExclusivesWorkplace Management

New FDA regulation for improving safety reporting in clinical trials discussed in The New England Journal of Medicine.

Share

The June 8 edition of The New England Journal of Medicine includes “New FDA Regulation to Improve Safety Reporting in Clinical Trials.” Read here.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

Get your free subscription to NurseLine!

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts